$MATN Mateon Therapeutics (OTCQB: MATN) to Develop its OT-101, a Phase 3 Clinical Drug Candidate, Initially Against COVID-19

https://t.co/wlfsBg90y4

$XYN $REGN $RGNX $BMY $LLY $ABT $PG $AMGN $GSK $GILD 

#CoronaVirus #Covid19  #HotStocks #EmergingGrowth #HighRiskHighReturns